Headquartered in Denmark, Novo Nordisk employs approximately 42,700 people in 79 countries and markets its products in more than 170 countries.
We have formulated positions on issues of relevance to our business and our role as a global corporate citizen. Topics are access to diabetes care, animal ethics, gene technology, climate change and many more.
The Apis bull has been Novo's logo since the year after the foundation of Novo Terapeutisk Laboratorium in 1925. The choice of the logo follows a European chemist tradition of identifying pharmacies through an animal symbol.